Nancy Hamel

6.3k total citations
58 papers, 2.4k citations indexed

About

Nancy Hamel is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Nancy Hamel has authored 58 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Genetics, 30 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in Nancy Hamel's work include BRCA gene mutations in cancer (27 papers), DNA Repair Mechanisms (18 papers) and Genomic variations and chromosomal abnormalities (8 papers). Nancy Hamel is often cited by papers focused on BRCA gene mutations in cancer (27 papers), DNA Repair Mechanisms (18 papers) and Genomic variations and chromosomal abnormalities (8 papers). Nancy Hamel collaborates with scholars based in Canada, United States and United Kingdom. Nancy Hamel's co-authors include William D. Foulkes, Pierre O. Chappuis, Nora Wong, Jean‐Sébastien Brunet, Marc Tischkowitz, Nelly Sabbaghian, Louis R. Bégin, John R. Goffin, Jeffrey P. Bond and Marc S. Greenblatt and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Nancy Hamel

54 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nancy Hamel Canada 25 1.3k 1.2k 650 633 494 58 2.4k
Bjarni A. Agnarsson Iceland 27 925 0.7× 799 0.7× 556 0.9× 714 1.1× 854 1.7× 80 2.7k
Stephen E. Karp United States 14 548 0.4× 568 0.5× 946 1.5× 783 1.2× 566 1.1× 23 2.2k
Maria J. Worsham United States 29 1.0k 0.8× 401 0.3× 516 0.8× 592 0.9× 303 0.6× 82 2.1k
Hannes Müller Austria 24 1.8k 1.4× 302 0.3× 727 1.1× 744 1.2× 396 0.8× 44 2.5k
Harald Blegen Sweden 18 860 0.7× 652 0.6× 755 1.2× 573 0.9× 520 1.1× 33 1.9k
Kerstin Heselmeyer‐Haddad United States 21 717 0.6× 362 0.3× 748 1.2× 612 1.0× 223 0.5× 47 1.7k
Mario Hermsen Spain 35 1.4k 1.1× 478 0.4× 718 1.1× 1.4k 2.2× 516 1.0× 148 3.7k
Johanna Tapper Finland 14 701 0.5× 410 0.4× 353 0.5× 339 0.5× 246 0.5× 22 1.4k
Cathy B. Moelans Netherlands 28 1.0k 0.8× 433 0.4× 719 1.1× 917 1.4× 196 0.4× 87 2.1k
Stephen Baylin United States 4 1.2k 1.0× 268 0.2× 687 1.1× 1.7k 2.7× 423 0.9× 7 2.5k

Countries citing papers authored by Nancy Hamel

Since Specialization
Citations

This map shows the geographic impact of Nancy Hamel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Hamel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Hamel more than expected).

Fields of papers citing papers by Nancy Hamel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy Hamel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Hamel. The network helps show where Nancy Hamel may publish in the future.

Co-authorship network of co-authors of Nancy Hamel

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Hamel. A scholar is included among the top collaborators of Nancy Hamel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Hamel. Nancy Hamel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Diaz-Papkovich, Alex, Guillaume Sillon, Daniela D’Agostino, et al.. (2025). Using the ancestral recombination graph to study the history of rare variants in founder populations. The American Journal of Human Genetics. 112(12). 2973–2981.
2.
Biswas, Kajal, Martin Couillard, Luca Cavallone, et al.. (2021). A novel mouse model of PMS2 founder mutation that causes mismatch repair defect due to aberrant splicing. Cell Death and Disease. 12(9). 838–838. 8 indexed citations
3.
Nadaf, Javad, Leanne de Kock, Anne‐Sophie Chong, et al.. (2021). Molecular characterization of DICER1-mutated pituitary blastoma. Acta Neuropathologica. 141(6). 929–944. 17 indexed citations
4.
Zayed, Nadia, Manon de Ladurantaye, Nancy Hamel, et al.. (2021). Current gene panels account for nearly all homologous recombination repair-associated multiple-case breast cancer families. npj Breast Cancer. 7(1). 109–109. 6 indexed citations
5.
Behl, Supriya, Nancy Hamel, Manon de Ladurantaye, et al.. (2020). Founder BRCA1/BRCA2/PALB2 pathogenic variants in French-Canadian breast cancer cases and controls. Scientific Reports. 10(1). 6491–6491. 20 indexed citations
6.
Shorstova, Tatiana, Maud Marques, Jie Su, et al.. (2019). SWI/SNF-Compromised Cancers Are Susceptible to Bromodomain Inhibitors. Cancer Research. 79(10). 2761–2774. 52 indexed citations
7.
Gavino, Christina, Nancy Hamel, Catherine Legault, et al.. (2015). Impaired RASGRF1/ERK–mediated GM-CSF response characterizes CARD9 deficiency in French-Canadians. Journal of Allergy and Clinical Immunology. 137(4). 1178–1188.e7. 63 indexed citations
8.
Hartley, Taila, Luca Cavallone, Nelly Sabbaghian, et al.. (2014). Mutation analysis of PALB2 in BRCA1 and BRCA2-negative breast and/or ovarian cancer families from Eastern Ontario, Canada. Hereditary Cancer in Clinical Practice. 12(1). 19–19. 18 indexed citations
9.
Sabbaghian, Nelly, Nancy Hamel, William D. Foulkes, et al.. (2013). Contribution of the PALB2 c.2323C>T [p.Q775X] Founder mutation in well-defined breast and/or ovarian cancer families and unselected ovarian cancer cases of French Canadian descent. BMC Medical Genetics. 14(1). 5–5. 17 indexed citations
10.
Hamel, Nancy, Louis R. Bégin, Tarek A. Bismar, et al.. (2013). Familial prostate cancer: the damage done and lessons learnt. Nature Reviews Urology. 10(2). 116–122. 4 indexed citations
11.
Domchek, Susan M., Jiang-bo Tang, Jill E. Stopfer, et al.. (2012). Biallelic Deleterious BRCA1 Mutations in a Woman with Early-Onset Ovarian Cancer. Cancer Discovery. 3(4). 399–405. 101 indexed citations
12.
Vijai, Joseph, Tomas Kirchhoff, David Gallagher, et al.. (2011). Genetic architecture of prostate cancer in the Ashkenazi Jewish population. British Journal of Cancer. 105(6). 864–869. 9 indexed citations
13.
Li, Lili, Kajal Biswas, Sergey G. Kuznetsov, et al.. (2009). Functional redundancy of exon 12 ofBRCA2revealed by a comprehensive analysis of the c.6853A>G (p.I2285V) variant. Human Mutation. 30(11). 1543–1550. 26 indexed citations
14.
Lane, Maureen E., Jeanne M. Fahey, Nancy Hamel, et al.. (2007). In vivo synergy between oncolytic reovirus and gemcitibane in ras-mutated human HCT116 xenografts. Cancer Research. 67. 4812–4812. 4 indexed citations
15.
Hamel, Nancy, et al.. (2007). Mixed Ovarian Germ Cell Tumor in a BRCA2 Mutation Carrier. International Journal of Gynecological Pathology. 26(2). 160–164. 6 indexed citations
16.
Mew, Nicholas Ah, et al.. (2002). Haplotype analysis of a BRCA1: 185delAG mutation in a Chilean family supports its Ashkenazi origins. Clinical Genetics. 62(2). 151–156. 13 indexed citations
17.
Pal, Tuya, Nancy Hamel, Danny Vesprini, et al.. (2001). Double primary cancers of the breast and thyroid in women: molecular analysis and genetic implications. Familial Cancer. 1(1). 17–24. 15 indexed citations
18.
Chappuis, Pierre O., Nancy Hamel, Jean Deschênes, et al.. (2001). Prevalence of founder BRCA1 and BRCA2 mutations in unselected French Canadian women with breast cancer. Clinical Genetics. 59(6). 418–423. 14 indexed citations
19.
Warner, Elizabeth, William D. Foulkes, Pamela J. Goodwin, et al.. (1999). Prevalence and Penetrance of BRCA1 and BRCA2 Gene Mutations in Unselected Ashkenazi Jewish Women With Breast Cancer. JNCI Journal of the National Cancer Institute. 91(14). 1241–1247. 306 indexed citations
20.
Migliaccio, Giovanni, Marta Baiocchi, Nancy Hamel, Keith Eddleman, & Anna Ritá Migliaccio. (1996). Circulating Progenitor Cells in Human Ontogenesis: Response to Growth Factors and Replating Potential. Journal of Hematotherapy. 5(2). 161–170. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bjarni A. Agnarsson Breakdown of academic impact, for papers by Stephen E. Karp Breakdown of academic impact, for papers by Maria J. Worsham Breakdown of academic impact, for papers by Hannes Müller Breakdown of academic impact, for papers by Harald Blegen Breakdown of academic impact, for papers by Kerstin Heselmeyer‐Haddad Breakdown of academic impact, for papers by Mario Hermsen Breakdown of academic impact, for papers by Johanna Tapper Breakdown of academic impact, for papers by Cathy B. Moelans Breakdown of academic impact, for papers by Stephen Baylin
Rankless by CCL
2026